Q4 2020 Holdings
Filed 2021-02-16 | 95 holdings | $36.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2021-05-05) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $5.1M | 361,930 | 14.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $4.9M | 432,563 | 13.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.2M | 239,520 | 11.5% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $4.2M | 61,991 | 11.4% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $4.1M | 293,917 | 11.2% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $3.8M | 216,925 | 10.3% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $3.3M | 185,552 | 9.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $1.9M | 250,000 | 5.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $1.8M | 273,703 | 4.9% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $1.8M | 62,962 | 4.9% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $1.3M | 332,258 | 3.5% |
| Ocuphire Pharma Inc(IRD) | COM | 67577R102 | $13.4K | 2,068,530 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $6.7K | 822,009 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $6.3K | 303,174 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $6.2K | 902,633 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $6.0K | 276,719 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.9K | 263,596 | 0.0% |
| Genprex Inc | COM | 372446104 | $5.9K | 1,409,785 | 0.0% |
| Verastem Inc | COM | 92337C104 | $5.8K | 2,731,974 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $5.6K | 261,209 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $5.1K | 1,682,535 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.0K | 148,743 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $4.9K | 153,348 | 0.0% |
| Immatics N.V.(IMTX)A | SHS | N44445109 | $4.4K | 405,670 | 0.0% |
| Arya Sciences Acquisition Co | COM CL A | G3166W106 | $4.3K | 400,000 | 0.0% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $4.3K | 218,650 | 0.0% |
| Eucrates Biomedical Acqu COR | UNIT 10/23/2027 | G3141W114 | $4.3K | 400,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $4.1K | 11,200 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $4.1K | 16,200 | 0.0% |
| Chardan Healthcr Acqstn 2 Co | COM | 15957T107 | $4.0K | 388,845 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $3.9K | 134,233 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.7K | 185,854 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $3.7K | 244,155 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $3.6K | 77,622 | 0.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $3.5K | 262,465 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $3.3K | 205,799 | 0.0% |
| Mict Inc(TIOG) | COM | 55328R109 | $3.2K | 1,533,425 | 0.0% |
| Vincera Pharma Inc | COM | 92731L106 | $3.1K | 150,150 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $3.1K | 465,589 | 0.0% |
| Haemonetics Corp(HAE) | COM | 405024100 | $3.1K | 26,144 | 0.0% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $3.1K | 400,000 | 0.0% |
| Orbital Energy Group Inc | COM | 68559A109 | $3.0K | 1,353,995 | 0.0% |
| Sientra Inc | COM | 82621J105 | $2.9K | 752,634 | 0.0% |
| Alpha Healthcare Acquistn Co | UNIT 09/21/2027 | 020751202 | $2.9K | 275,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $2.8K | 250,000 | 0.0% |
| Nano Dimension LTD(NNDM) | SPONSORD ADS NEW | 63008G203 | $2.8K | 304,600 | 0.0% |
| Lifesci Acquisition II Corp | COM | 53229E103 | $2.7K | 250,000 | 0.0% |
| Consonance HFW Acquisition C | UNIT 99/99/9999 | G2445M129 | $2.6K | 250,000 | 0.0% |
| Turmeric Acquisition Corp | UNIT 10/08/2025 | G9127T116 | $2.6K | 254,000 | 0.0% |
| FS DEV Corp | COM CL A | 303020101 | $2.6K | 234,000 | 0.0% |